These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35272494)

  • 1. A Double-Blind Placebo-Controlled, Randomized Trial of Divalproex Sodium for Posttraumatic Irritability Greater Than 1 Year After Mild to Moderate Traumatic Brain Injury.
    Beresford T; Ronan PJ; Hipp D; Schmidt B; Thumm EB; Temple B; Wortzel H; Weitzenkamp D; Emrick C; Kelly J; Arciniegas DB
    J Neuropsychiatry Clin Neurosci; 2022; 34(3):224-232. PubMed ID: 35272494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine for Irritability and Aggression after Traumatic Brain Injury: A Randomized, Placebo-Controlled Study.
    Hammond FM; Zafonte RD; Tang Q; Jang JH
    J Neurotrauma; 2021 Aug; 38(16):2238-2246. PubMed ID: 33563104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study.
    Hammond FM; Sherer M; Malec JF; Zafonte RD; Whitney M; Bell K; Dikmen S; Bogner J; Mysiw J; Pershad R;
    J Neurotrauma; 2015 Aug; 32(16):1230-8. PubMed ID: 25774566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
    Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F
    J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.
    Hollander E; Chaplin W; Soorya L; Wasserman S; Novotny S; Rusoff J; Feirsen N; Pepa L; Anagnostou E
    Neuropsychopharmacology; 2010 Mar; 35(4):990-8. PubMed ID: 20010551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttraumatic Stress Disorder Symptoms Contribute to Staff Perceived Irritability, Anger, and Aggression After TBI in a Longitudinal Veteran Cohort: A VA TBI Model Systems Study.
    Miles SR; Brenner LA; Neumann D; Hammond FM; Ropacki S; Tang X; Eapen BC; Smith A; Nakase-Richardson R
    Arch Phys Med Rehabil; 2020 Jan; 101(1):81-88. PubMed ID: 31513779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the benefits and risks of amantadine for irritability and aggression after traumatic brain injury.
    Hammond FM; Zafonte RD; Sherer M; Bell KR; Bogner J; Malec JF; Tang Q; Jang JH
    PM R; 2024 Jul; 16(7):661-668. PubMed ID: 38145314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary controlled trial of divalproex in posttraumatic stress disorder.
    Hamner MB; Faldowski RA; Robert S; Ulmer HG; Horner MD; Lorberbaum JP
    Ann Clin Psychiatry; 2009; 21(2):89-94. PubMed ID: 19439158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, placebo-controlled trial of a computer-based Interpretation Bias Training for youth with severe irritability: a study protocol.
    Haller SP; Stoddard J; MacGillivray C; Stiles K; Perhamus G; Penton-Voak IS; Bar-Haim Y; Munafò MR; Brotman MA
    Trials; 2018 Nov; 19(1):626. PubMed ID: 30428909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression.
    Hammond FM; Bickett AK; Norton JH; Pershad R
    J Head Trauma Rehabil; 2014; 29(5):391-9. PubMed ID: 24263176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD; Redden L; Kowatch RA; Wilens TE; Segal S; Chang K; Wozniak P; Vigna NV; Abi-Saab W; Saltarelli M
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial.
    Deb S; Aimola L; Leeson V; Bodani M; Li L; Weaver T; Sharp D; Bassett P; Crawford M
    BMJ Open; 2020 Sep; 10(9):e036300. PubMed ID: 32912978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis.
    Elshafay A; Hieu TH; Doheim MF; Kassem MAM; ELdoadoa MF; Holloway SK; Abo-Elghar H; Hirayama K; Huy NT
    CNS Drugs; 2019 Mar; 33(3):239-250. PubMed ID: 30796634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
    Hirschfeld RM; Baker JD; Wozniak P; Tracy K; Sommerville KW
    J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
    Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
    JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.